Vaxcyte (FRA:5VA) Short Interest


FRA:5VA Vaxcyte Inc FRA:5VA
35 GF Score
Price €44.40
! 3 Warning Signs
View Full Analysis

What is Vaxcyte Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:5VA vs CORT, IBRX, HALO: Short Interest Comparison

For the Biotechnology subindustry, Vaxcyte's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vaxcyte Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxcyte's Short Interest distribution charts can be found below:

* The bar in red indicates where Vaxcyte's Short Interest falls into.


FRA:5VA
35GF Score
Vaxcyte Inc FRA:5VA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxcyte Business Description

Other Exchanges PCVX:USA1PCVX:Italy
Address 825 Industrial Road, Suite 300, San Carlos, CA, USA, 94070
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
35GF Score

Get the complete analysis for FRA:5VA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€44.40
Price